A Phase II Study of TollB-001 Tablets in Systemic Sclerosis
Clinical trial NCT07745725 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07745725
- Sponsor
- Toll Biotech Co. Ltd. (Beijing)
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2027-10-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.